- Real Estate
- Food & Drink
Nov. 1, 2018
Four medical pioneers have been named finalists for Sanford Health’s new $1 million Lorraine Cross Award, with achievements that include reversing a rare form of blindness, enabling children to walk and setting the ethical standard for all gene therapy trials.
The award will be given for contributions to medicine, science and innovation in a Dec. 4 ceremony in Sioux Falls.
“To find our four finalists, we identified medical and research pioneers, which led us specifically to the field of gene therapy,” said David Pearce, president of research at Sanford Health. “These four finalists helped lay the groundwork for much of what is being explored now, and we want to honor them for that.”
The finalists are:
In December, the Sanford International Board will hear presentations from the award finalists.
“These individuals are changing the world,” said David Shulkin, international board member and Sanford Health chief of innovation. “At Sanford, we want to reward innovation and scientific breakthroughs. We’re committed to finding the next frontier in medicine and research, and recognizing others with the same goal.”
Candidates for the award were filtered through nominations from the public and a computer algorithm that sifted through medical publications in search of great discoveries. An interdisciplinary scientific advisory board identified top areas of innovation, and the candidates were narrowed down to the top four.
The award is named after the Lorraine Cross, a symbol recognized around the world as synonymous for those who take action for their passions. In recent history, Sanford has used it to symbolize innovation in health care.
They reversed blindness, helped children walk and set the standard for all gene therapy trials. Meet the finalists for Sanford’s first $1 million Lorraine Cross Award.